Study of SZC and Enhanced Nutrition Advice Compared to SoC in Dialysis Patients with Hyperkalaemia

Trial Identifier:	D9480C00014
Sponsor:	AstraZeneca
NCTID::	NCT04997161
Start Date:	August 2021
Primary Completion Date:	November 2021
Study Completion Date:	November 2021

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Version

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

No locations posted.

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.